The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers
- 31 January 2005
- journal article
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 96 (1), 222-226
- https://doi.org/10.1016/j.ygyno.2004.09.039
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Contralateral Breast Cancer in BRCA1 and BRCA2 Mutation CarriersJournal of Clinical Oncology, 2004
- Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2Science, 2003
- BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cellsBritish Journal of Cancer, 2003
- Cancer risk in women with previous breast cancerAnnals Of Oncology, 2003
- Risk of ovarian cancer in breast-cancer patients with a family history of breast or ovarian cancer: a population-based cohort studyThe Lancet, 2002
- Cancer Risk Estimates for BRCA1 Mutation Carriers Identified in a Risk Evaluation ProgramJNCI Journal of the National Cancer Institute, 2002
- Prophylactic Oophorectomy in Carriers ofBRCA1orBRCA2MutationsNew England Journal of Medicine, 2002
- Scottish Adjuvant Tamoxifen Trial: a Randomized Study Updated to 15 YearsJNCI Journal of the National Cancer Institute, 2001
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesAmerican Journal of Human Genetics, 1998
- Ovarian ablation in early breast cancer: overview of the randomised trialsThe Lancet, 1996